USRE36477EExpiredUtility

Benzoic acid derivatives and process for preparing the same

45
Assignee: TAIHO PHARMACEUTICAL CO LTDPriority: Mar 29, 1988Filed: Jun 25, 1998Granted: Dec 28, 1999
Est. expiryMar 29, 2008(expired)· nominal 20-yr term from priority
Inventors:Koichi Shudo
C07F 7/30C07F 7/081
45
PatentIndex Score
3
Cited by
11
References
1
Claims

Abstract

Benzoic acid derivatives represented by the formula (I): wherein R1 represents hydrogen or lower-alkyl, R2 and R4 represent hydrogen, trimethylsilyl, or trimethylgermyl, R3 represents hydrogen, lower-alkyl, trimethylsilyl, or trimethylgermyl, R5 represents hydrogen, lower-alkyl, acetyl, or hydroxy, at least one of R2 and R3 being trimethylsilyl or trinethylgermyl, and R6 means hydroxy, lower-alkoxy, or a group of the formula -NR7R8, wherein R7 and R8 mean hydrogen or lower-alkyl, and X represents a group of the formula -CONH-, -NHCO-, -COO-, -OCO-, -COCH=CH-, -COCH=C(OH), or -CH=CH-, which exhibit excellent effect as differentiation-inducing agents for neoplastic cells, especially leukemia cells, or a therapeutic agent for psoriasis or immune and inflammatory diseases, and a process for the preparation thereof, are disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is: .[. 
     
       1.  A benzoic acid derivative represented by the formula (I) ##STR24## wherein R 1  represents hydrogen or lower-alkyl, R 2  and R 4  represent hydrogen or trimethylsilyl, R 3  represents hydrogen, lower-alkyl, or trimethylsilyl, R 5  represents hydrogen, lower-alkyl, acetyl or hydroxy, at least one of R 2  and R 3  being trimethylsilyl, and R 6  means hydroxy, lower-alkoxy, or a group of the formula --NR 7  R 8 , wherein R 7  and R 8  mean hydrogen or lower-alkyl, and X represents a group of the formula --CONH--, --NHCO--, --COO--, --COCH═CH--, --COCH═C(OH)--, or --CH═CH--..]..[.2. A compound of claim 1 which is 4-[3,5-Bis(trimethylsilyl) 
     
     
        phenylcarbamoyl]benzoic acid..].3. A compound .[.of claim 1.]. which is 4-[3,5-Bis(trimethylsilyl) phenylcarboxamido]benzoic acid. .[.4. A compound of claim 1 which is 4-[3-[3,5-Bis(trimethylsilyl) phenyl]-3-oxo-1-propenyl]benzoic acid..]..[.5. A compound of claim 1 which is 4-[1-Hydroxy-3-(2-hydroxy-5-trimethylsilylphenyl)-3-oxo-1-propenyl]benzoic acid..]..[.6. A compound of claim 1 which is 4-(3-trimethylsilylphenylcarbamoyl)benzoic acid..]..[.7. A compound of claim 1 which is methyl 4-[3,5-bis(trimethylsilyl)phenylcarboxy]benzoate..]..[.8. A compound of claim 1 which is 4-[(3-trimethylsilylphenyl) ethenyl]benzoic acid..]..[.9. A compound of claim 1 which is 4-[3-(3-trimethylsilylphenyl)-3-oxo-1-propenyl]benzoic acid..]..[.10. A compound of claim 1 which is 4-[1-hydroxy-3-(2-hydroxy-4-trimethylsilylphenyl)-3-oxo-1-propenyl]benzoic 
     
     
        acid..].11. A method of differentiating neoplastic cells which are susceptible thereto comprising the step of employing, as the active differentiation-inducing reagent, an amount of a compound as claimed in claim .[.1.]. .Iadd.3 .Iaddend.which is effective for such purpose. .[.12. The method of claim 11, wherein the neoplastic cells are leukemia cells..]..[.13. A therapeutic agent useful for treatment of psoriasis comprising as active ingredient an effective amount of a compound as claimed in claim 1, together with a pharmaceutically-acceptable diluent or carrier..]..[.14. A therapeutic agent useful for treatment of immune and inflammatory diseases which are susceptible thereto comprising as active ingredient an effective amount of a compound as claimed in claim 1, together with a pharmaceutically-acceptable diluent or carrier..].

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.